RAFAEL HOLDINGS, INC. Interest Expense, Federal Funds Purchased
RAFAEL HOLDINGS, INC. (RFL) had Interest Expense, Federal Funds Purchased of $49.40 million as of 2022-08-22, per its 10-K/A filed 2024-12-20.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseFederalFundsPurchased · last filed 2024-12-20
- 2022-08-22: Interest Expense, Federal Funds Purchased $49.40M.
| Period end | Interest Expense, Federal Funds Purchased |
|---|---|
| 2022-08-22 | $49.40M 10-K/A · filed 2024-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |